|
Invited Speakers:
|
|
-- Steve G. Farrand, Ph.D. , Vice President, BioProcess Development, Merck Research Laboratories
-- Wassim Nashabeh, Ph.D., Global Head, Technical Regulatory Policy & Strategy, Genentech, a member of the Roche Group
-- Mark von Stwolinski, Vice President of Architectural Services, Clark Richardson & Biskup (CRB) Consulting Engineers
-- Chulani Karunatilake, Ph.D., Director, Analytical Sciences, Amgen Inc.
-- Frank Ho, Ph.D., Vice President, Biologics Operations, PharmaEssentia
|
|